Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-045469
Filing Date
2011-08-11
Accepted
2011-08-11 07:38:01
Documents
1
Period of Report
2011-08-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v231625_4.html 4  
1 OWNERSHIP DOCUMENT v231625_4.xml 4 3965
  Complete submission text file 0001144204-11-045469.txt   5245
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PFIZER INC ATTN CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017
Business Address
FECZKO JOSEPH M (Reporting) CIK: 0001319874 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 111025931